MX2018013438A - Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal. - Google Patents

Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal.

Info

Publication number
MX2018013438A
MX2018013438A MX2018013438A MX2018013438A MX2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A
Authority
MX
Mexico
Prior art keywords
colorectal cancer
pharmaceutical compositions
effective treatment
kras4b
compound
Prior art date
Application number
MX2018013438A
Other languages
English (en)
Inventor
NOVA Predro CRUZ
Díaz Paola Briseño
Mejia Miguel Ángel Vargas
Original Assignee
Centro De Investig Y De Estudios Avanzados Del I P N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y De Estudios Avanzados Del I P N filed Critical Centro De Investig Y De Estudios Avanzados Del I P N
Priority to MX2018013438A priority Critical patent/MX2018013438A/es
Priority to PCT/IB2019/059380 priority patent/WO2020089842A1/en
Publication of MX2018013438A publication Critical patent/MX2018013438A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La presente invención describe composiciones farmacéuticas que comprenden el compuesto de fórmula (ver Fórmula) (compuesto C19) que inhibe específicamente la GTPasa KRAS4b mutada, por lo que resultan útiles para el tratamiento efectivo del cáncer colorectal. El compuesto C19 funciona como un estabilizador del complejo KRAS4b-PDEd, disminuyendo la proliferación de células cancerosas en cáncer colorectal, y aumentando la apoptosis a través de la disminución de la activación de la señalización oncogénica de KRAS4b.
MX2018013438A 2018-11-01 2018-11-01 Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal. MX2018013438A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2018013438A MX2018013438A (es) 2018-11-01 2018-11-01 Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal.
PCT/IB2019/059380 WO2020089842A1 (en) 2018-11-01 2019-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018013438A MX2018013438A (es) 2018-11-01 2018-11-01 Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal.

Publications (1)

Publication Number Publication Date
MX2018013438A true MX2018013438A (es) 2022-07-20

Family

ID=70463876

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013438A MX2018013438A (es) 2018-11-01 2018-11-01 Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal.

Country Status (2)

Country Link
MX (1) MX2018013438A (es)
WO (1) WO2020089842A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054572A1 (en) * 2013-10-10 2015-04-16 Araxes Pharma Llc Inhibitors of kras g12c

Also Published As

Publication number Publication date
WO2020089842A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
MX2023005804A (es) Piridazinonas como inhibidoras de poli(adenosin difosfato-ribosa) polimerasa 7 (parp7).
GEP20217281B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
PH12020500033A1 (en) Macrocyclic compounds and uses thereof
EA201990187A1 (ru) Антипролиферационные средства на основе пиримидина
ZA201906832B (en) Novel psma-binding agents and uses thereof
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
GEP20186933B (en) Substituted dihydroisoquinoline compounds
MX2020006365A (es) Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14).
MX2022001310A (es) Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo.
MX2020009413A (es) Celulas t car-cd30 para el tratamiento de tumores cd30+.
TN2019000211A1 (en) Antitumoral compounds
MX2019010149A (es) Inhibicion del smarca2 para el tratamiento del cancer.
MX2018006953A (es) Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer.
EP4306173A3 (en) Compositions and methods for treating cancers
WO2019023315A3 (en) RAC INHIBITORS
MX2019002430A (es) Agente antitumoral, mejorador del efecto antitumoral, y kit antitumoral.
PH12017500910A1 (en) Use of sigma receptor ligands in osteoarthritis
MX2021008225A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
EA201691896A1 (ru) Соединения и способы их применения
MX2018013438A (es) Composiciones farmaceuticas para el tratamiento efectivo de cancer colorectal.
WO2018146390A8 (fr) Utilisation d'un compose appartenant a la famille des diuretiques pour traiter le cancer
MX2018001575A (es) Compuestos triciclicos y su uso en el tratamiento del cancer.
MX2021011699A (es) Derivados de quinolina y su uso para el tratamiento del cancer.
MX2018002612A (es) Composicion farmaceutica para tumor que tiene mutacion de isocitrato deshidrogenada, agente antitumoral y uso del mismo.
MX2017014463A (es) Cabazitaxel y su uso para tratar cancer.